Old Web
English
Sign In
Acemap
>
Paper
>
Benefits of mTOR kinase targeting in oncology: pre-clinical evidence with AZD8055: Figure 1
Benefits of mTOR kinase targeting in oncology: pre-clinical evidence with AZD8055: Figure 1
2011
Gayle Marshall
Zoe Howard
Jonathan R. Dry
Sarah Fenton
Dan Heathcote
Neil Gray
Heather Keen
Armelle Logie
Sarah Holt
Paul Smith
Sylvie Guichard
Keywords:
PI3K/AKT/mTOR pathway
Oncology
Kinase
Biology
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
12
References
0
Citations
NaN
KQI
[]